Aprea Therapeutics to Host Virtual R&D Day on April 22, 2021
BOSTON, April 16, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing…
Pharmaceuticals, Biotechnology and Life Sciences
BOSTON, April 16, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing…
Oslo, Norway, 16 April 2021 Vistin Pharma ASA will release its first quarter 2021 results on Friday 23rd of April 2021.…
UPPSALA, SWEDEN – LIDDS publishes Annual Report for 2020 The Annual Report is attached to this press release and alos…
— Adverum to host webcast with key opinion leaders on Sunday, May 2, 2021 at 7:00 AM PT — REDWOOD CITY, Calif.,…
Seizure Related Benefits noted by caregivers included reduction in frequency, fewer triggers causing seizures, and shorter recovery time when seizure…
TORONTO, April 16, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) will…
TEMPLE CITY, Calif., April 16, 2021 (GLOBE NEWSWIRE) — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a…
SYDNEY, AUSTRALIA, April 16, 2021 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”), is pleased…
MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced…
TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty…